Gi Jung Im Selected Research

Resveratrol

7/2015	Response to the Letter to the Editor regarding "Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells".
1/2015	Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gi Jung Im Research Topics

Disease

22	Ototoxicity 12/2022 - 05/2007
5	Hearing Loss (Hearing Impairment) 01/2023 - 05/2007
4	Tinnitus 01/2021 - 05/2007
3	Infections 12/2023 - 01/2015
3	Sensorineural Hearing Loss 03/2021 - 04/2010
2	Otitis Media 10/2016 - 01/2015
2	Inflammation (Inflammations) 10/2016 - 05/2014
2	Cholesteatoma 02/2013 - 02/2012
1	Fistula 12/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Facial Paralysis (Facial Palsy) 01/2023
1	Dizziness (Lightheadedness) 09/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Hidden Hearing Loss 01/2021
1	Necrosis 07/2016
1	Deafness (Deaf Mutism) 05/2014
1	Otosclerosis 10/2011
1	Nasal Obstruction 05/2008

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 04/2010
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2009
5	Neomycin FDA LinkGeneric 01/2016 - 12/2013
4	Metformin (Glucophage)FDA LinkGeneric 12/2022 - 12/2011
4	SalicylatesIBA 09/2010 - 05/2007
3	EdaravoneIBA 12/2015 - 06/2013
3	CalciumIBA 04/2014 - 12/2011
2	SteroidsIBA 01/2021 - 06/2012
2	ResveratrolIBA 07/2015 - 01/2015
2	Free RadicalsIBA 08/2014 - 05/2014
2	Messenger RNA (mRNA)IBA 02/2013 - 09/2010
2	Gentamicins (Gentamicin)FDA LinkGeneric 12/2011 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 05/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Capsules (Microcapsules)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	ThioredoxinsIBA 12/2022
1	SolutionsIBA 09/2021
1	Thioctic Acid (Lipoic Acid)IBA 12/2016
1	Glutathione (Reduced Glutathione)IBA 12/2016
1	LipopolysaccharidesIBA 10/2016
1	tianeptine (Stablon)IBA 09/2016
1	alpha-Tocopherol FDA Link 07/2016
1	Tocopherols (Tocopherol)IBA 07/2016
1	acivicin (AT 125)IBA 07/2016
1	AntioxidantsIBA 07/2016
1	Sodium SeleniteIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	EugenolIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Oxygen (Dioxygen)IBA 08/2014
1	AminoglycosidesIBA 08/2014
1	caffeic acid phenethyl esterIBA 08/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2014
1	Neuroprotective AgentsIBA 05/2014
1	NecroX-5IBA 02/2014
1	rac1 GTP-Binding ProteinIBA 02/2013
1	acetovanillone (apocynin)IBA 02/2013
1	Acetic Acid (Vinegar)FDA LinkGeneric 02/2012
1	Insulin-Like PeptidesIBA 09/2010
1	Antineoplastic Agents (Antineoplastics)IBA 04/2010
1	A-Form DNA (A-DNA)IBA 05/2008
1	OligonucleotidesIBA 05/2007

Therapy/Procedure

1	Suture Techniques 12/2023
1	Glycemic Control 03/2021
1	Cochlear Implants (Cochlear Implant) 12/2015
1	Debridement 02/2012
1	Therapeutics 02/2012
1	Ossicular Prosthesis (TORP) 10/2011
1	Cautery 05/2008